ETR:SAE Shop Apotheke Europe (SAE) Stock Price, News & Analysis → Central Banks Preparing for US Dollar Collapse? (From Behind the Markets) (Ad) Free SAE Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume73,581 shsAverage VolumeN/AMarket Capitalization$1.66 billionP/E RatioN/ADividend YieldN/APrice Target€114.50 Stock AnalysisStock AnalysisAnalyst ForecastsHeadlinesStock AnalysisAnalyst ForecastsHeadlines Get Shop Apotheke Europe alerts: Email Address Ad Behind the MarketsCentral Banks Preparing for US Dollar Collapse?China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.Find out how you can protect yourself now >>> About Shop Apotheke Europe Stock (ETR:SAE)Shop Apotheke Europe N.V. owns and operates online pharmacies in Germany, Austria, Switzerland, France, Belgium, Italy, and the Netherlands. It provides prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products, as well as food supplements. The company was founded in 2001 and is headquartered in Sevenum, the Netherlands.Read More Ad Behind the MarketsCentral Banks Preparing for US Dollar Collapse?China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.Find out how you can protect yourself now >>> SAE Stock News HeadlinesFebruary 18, 2024 | bbc.comSwiss antisemitism shock at Davos shop sign saying no skis for JewsAugust 21, 2023 | thestreet.comHuawei to Reopen Shop in U.S., but Can't Lose Sight of EuropeMarch 29, 2024 | Behind the Markets (Ad)Central Banks Preparing for US Dollar Collapse?China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.July 18, 2023 | finance.yahoo.comSAE.HA - Shop Apotheke Europe NVJune 14, 2023 | finanznachrichten.deUPDATE: Aus Shop Apotheke Europe wird Redcare Pharmacy - Interview mit CFO und COOJune 13, 2023 | finanznachrichten.deAus Shop Apotheke Europe wird Redcare Pharmacy - E-Rezept-News beflügelnJune 8, 2023 | msn.comSRH ALSTERRESEARCH AG Upgrades SHOP APOTHEKE EUROPE NV EUR.02 (FWB:SAE)May 31, 2023 | finance.yahoo.comShop Apotheke Europe (ETR:SAE) pulls back 5.4% this week, but still delivers shareholders impressive 17% CAGR over 5 yearsMarch 29, 2024 | Behind the Markets (Ad)Central Banks Preparing for US Dollar Collapse?China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.May 23, 2023 | markets.businessinsider.comEQS-Adhoc: Redcare Pharmacy N.V. (formerly SHOP APOTHEKE EUROPE N.V.): Termination of voting pool agreement.May 4, 2023 | finance.yahoo.comShop Apotheke Europe Reports First Quarter 2023 EarningsMay 2, 2023 | marketwatch.comEQS-News: SHOP APOTHEKE EUROPE: STRONG Q1 WITH 22% SALES GROWTH AND EBITDA MARGIN IN UPPER PART OF FULL-YEAR GUIDANCE.May 2, 2023 | de.finance.yahoo.comSHOP APOTHEKE EUROPE: STARKES ERSTES QUARTAL MIT 22 PROZENT UMSATZWACHSTUM UND EINER EBITDA-MARGE IM OBEREN PROGNOSEBEREICH.May 2, 2023 | uk.finance.yahoo.comSHOP APOTHEKE EUROPE: STRONG Q1 WITH 22% SALES GROWTH AND EBITDA MARGIN IN UPPER PART OF FULL-YEAR GUIDANCE.April 27, 2023 | marketwatch.comEQS-News: Successful Outcome for SHOP APOTHEKE EUROPE's Annual General Meeting 2023: Approval of New CEO and Change of Corporate Name.April 27, 2023 | uk.finance.yahoo.comSuccessful Outcome for SHOP APOTHEKE EUROPE's Annual General Meeting 2023: Approval of New CEO and Change of Corporate Name.April 17, 2023 | finance.yahoo.comWhile institutions own 34% of Shop Apotheke Europe N.V. (ETR:SAE), retail investors are its largest shareholders with 60% ownershipMarch 15, 2023 | uk.finance.yahoo.comSHOP APOTHEKE EUROPE N.V.: Olaf Heinrich shall become the new CEOMarch 15, 2023 | de.finance.yahoo.comSHOP APOTHEKE EUROPE N.V.: Olaf Heinrich soll neuer Vorstandsvorsitzender werdenMarch 7, 2023 | finanznachrichten.deSHOP APOTHEKE EUROPE N.V.: Keine Verlängerung der Amtszeit als Vorstandsvorsitzender durch Stefan FeltensMarch 6, 2023 | uk.finance.yahoo.comSHOP APOTHEKE EUROPE N.V.: No prolongation of his term as CEO by Stefan FeltensFebruary 16, 2023 | finanznachrichten.deShop Apotheke: Kurs kämpft mit wichtigem Widerstand!January 20, 2023 | finance.yahoo.comA Look At The Fair Value Of Shop Apotheke Europe N.V. (ETR:SAE)January 5, 2023 | finanznachrichten.deShop Apotheke: Marktteilnehmer kommen zurück!December 1, 2022 | ca.finance.yahoo.comShareholders in Shop Apotheke Europe (ETR:SAE) have lost 71%, as stock drops 6.1% this past weekNovember 28, 2022 | finance.yahoo.comShop Apotheke Europe N.V.'s (ETR:SAE) top owners are individual investors with 57% stake, while41% is held by institutionsOctober 5, 2022 | marketwatch.comShop Apotheke Shares Rise After Reporting Strong 3QSee More Headlines Receive SAE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Shop Apotheke Europe and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeETR SectorMedical Industry Pharmaceutical Retailers Sub-IndustryN/A Current SymbolETR:SAE CUSIPN/A CIKN/A Webshop-apotheke-europe.com Phone800 200 800 300FaxN/AEmployees1,638Year FoundedN/APrice Target and Rating Average Stock Price Target€114.50 High Stock Price Target€140.00 Low Stock Price Target€85.00 Consensus Rating Rating Score (0-4)0.00 Research Coverage0 Analysts Profitability EPS (Most Recent Fiscal Year)(€3.32) Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth0.2Net Income$-64,940,000.00 Net Margins-5.11% Pretax MarginN/A Return on Equity-17.45% Return on Assets-3.07% Debt Debt-to-Equity Ratio74.08 Current Ratio2.39 Quick Ratio2.28 Sales & Book Value Annual Sales$1.27 billion Price / Sales0.00 Cash FlowN/A Price / Cash Flow3.50 Book Value€19.49 per share Price / BookN/AMiscellaneous Outstanding Shares18,200,000Free FloatN/AMarket Cap$1.66 billion OptionableNot Optionable Beta0.88 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Stephan Weber (Age 44)Co-Founder, Chief Commercial Officer, Deputy CEO & Member of the Managing Board Comp: $252.27kMr. Marc Fischer (Age 48)Co-Founder, Chief Information Officer & Member of the Managing Board Comp: $251.72kMr. Jasper F. P. Eenhorst (Age 50)CFO & Member of Management Board Comp: $445kMs. Theresa Holler (Age 50)COO & Member of the Managing Board Comp: $256.93kMonica AmbrosiAssociate Director of Investor RelationsMr. Patrick SchneiderChief Sales OfficerMs. Beate KroschDirector of HRMr. Nana LohmannsChief E-Health OfficerMr. Dirk BruseChief Brand OfficerMr. Jens WolfgartenChief Product Officer - RetailMore ExecutivesKey CompetitorsCompuGroup Medical SE & Co. KGaAETR:COPEvotecETR:EVTBiotest AktiengesellschaftETR:BIOMorphoSysETR:MORRHÖN-KLINIKUM AktiengesellschaftETR:RHKView All Competitors SAE Stock Analysis - Frequently Asked Questions What is Shop Apotheke Europe's stock price target for 2024? 0 Wall Street research analysts have issued 1-year target prices for Shop Apotheke Europe's stock. Their SAE share price targets range from €85.00 to €140.00. On average, they predict the company's share price to reach €114.50 in the next year. View analysts price targets for SAE or view top-rated stocks among Wall Street analysts. What other stocks do shareholders of Shop Apotheke Europe own? Based on aggregate information from My MarketBeat watchlists, some companies that other Shop Apotheke Europe investors own include AbbVie (ABBV), Carl Zeiss Meditec (AFX), Allianz (ALV), Alimentation Couche-Tard (ANCUF), Bank of Montreal (BMO), Gilead Sciences (GILD), Mastercard (MA) and Merck & Co., Inc. (MRK). This page (ETR:SAE) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyMost important medical advance in 100 yearsThe Oxford ClubBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shop Apotheke Europe Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.